Ascentage Pharma Group International (AAPG) Shares Outstanding (Weighted Average) (2022 - 2025)

Ascentage Pharma Group International (AAPG) has 4 years of Shares Outstanding (Weighted Average) data on file, last reported at $52.6 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 19.94% year-over-year to $52.6 million; the trailing twelve-month figure through Dec 2025 stood at $52.6 million (up 19.94% YoY), and the FY2025 full-year result was $37000.0, up 27.59% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $52.6 million, up from $43.9 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $52.6 million in Q4 2025 and bottomed at $37.1 million in Q4 2022.
• The 4-year median for Shares Outstanding (Weighted Average) is $41.5 million (2023), against an average of $43.2 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) climbed 5.75%; it then advanced 19.94% in 2025.
• A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $37.1 million in 2022, then gained by 5.75% to $39.2 million in 2023, then gained by 11.93% to $43.9 million in 2024, then rose by 19.94% to $52.6 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $52.6 million (Q4 2025), $43.9 million (Q4 2024), and $39.2 million (Q4 2023), per Business Quant data.

Peer Comparison